Dacomitinib

ATC L01EB07 · 9 markets · 23 records

Dacomitinib 9 markets · 23 records Forms
Filters

US 3 records · 3 shown of 3 Source openFDA NDC Directory · Data as of 2026-10-23

GB 3 records · 3 shown of 3 Source NHSBSA dm+d · Data as of 2026-10-19

SG 3 records · 3 shown of 3 Source Health Sciences Authority (HSA) · Data as of 2026-08-07

TW 3 records · 3 shown of 3 Source 衛生福利部食品藥物管理署(TFDA)全部藥品許可證資料集 · Data as of 2026-10-22

  • 30 mgtabletVizimpro肺欣妥膜衣錠30毫克 also in US·GB·SG
    +1Other 1 marketsES
  • 15 mgtabletVizimpro肺欣妥膜衣錠15毫克 also in US·GB·SG
    +1Other 1 marketsES
  • 45 mgtabletVizimpro肺欣妥膜衣錠45毫克 also in US·GB·SG

HK 3 records · 0 shown of 0 Source 衞生署藥物辦公室(香港)註冊藥劑製品名單 · Data as of 2026-10-23 · some records have no stated strength · includes records with unknown status (not proof of sale)

3 records · 0 manufacturers 3 registros · 0 fabricantes 3 个记录 · 0 个厂家 3 個記錄 · 0 個廠商

ES 2 records · 2 shown of 2 Source CIMA (AEMPS) · Data as of live

MX 1 records · 0 shown of 0 Source COFEPRIS · Data as of annual · some records have no stated strength

1 records · 0 manufacturers 1 registros · 0 fabricantes 1 个记录 · 0 个厂家 1 個記錄 · 0 個廠商

EU 1 records · 0 shown of 0 Source European Commission · Data as of 2026-11-03 · some records have no stated strength

EU centralised authorisation (EMA) — Authorised at EU level — not a record of sale in any single country. The EU register carries no strength, dosage form or pack size.

1 records · 0 manufacturers 1 registros · 0 fabricantes 1 个记录 · 0 个厂家 1 個記錄 · 0 個廠商

Side-by-side table

The same ingredient can carry completely different brand names in different countries, and the same name can point to a different ingredient. Listed by country — not interchangeable.

Discontinued, withdrawn or unverified-status products are hidden by default; Hong Kong and Australia records are shown as exceptions.